The Effectiveness of Tailored Messages on the Usage of Emollient in Patients With Atopic Dermatitis

Not Applicable

Completed

• Conditions: Dermatitis, Atopic

• Registration Number: NCT02343861
• Lead Sponsor: Seoul National University Hospital

Brief Summary

Atopic dermatitis is the most common chronic inflammatory skin disease in children and severely affects quality of life (QoL) of patients and their parents. The application of topical medications and emollient is the mainstay of the treatment, but complexity of the treatment and lack of self-care knowledge cause poor adherence, leading to therapeutic failure. Adequate education about the chronic disease and its treatment was known to improve the treatment adherence. There are a variety forms like generalized information leaflets and video clips for imparting information to patients and individualized tailoring education was considered more effective way to improve patients' adherence. The aim of this study is to determine the efficacy of tailored education in dermatology area, especially the emollient usage in patients with atopic dermatitis.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-01
• Study First Submitted: 2015-01-16
• Study First Submitted QC: 2015-01-16
• Study First Posted: 2015-01-22
• Primary Completion: 2015-05
• Study Completion: 2015-05
• Status Verified: 2018-03
• Last Update Submitted: 2018-03-14
• Last Update Posted: 2018-03-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• A parent of 0-5 year old children with mild to moderate atopic dermatitis
• 20 years of age or older
• Apply emollient for themselves to their children with atopic dermatitis

Exclusion Criteria

• Parents of children with severe atopic dermatitis or showing signs of acute infection (Oozing, vesicles, edema, redness or pain)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Change of the weekly amount of emollient used	Two weeks	Parents of patients are asked to bring the emollients to each visit at which time the emollients are weighed.

Secondary Outcome Measures

Name	Time	Method
Average daily number of topical medication (other than emollient) usage	Two weeks
Average daily number of emollient usage	Two weeks
Investigator's Global Assessment (IGA)	Two weeks	At each visit, disease severity will be assessed using the Investigator's Global Assessment (IGA).
Eczema Area and Severity Index (EASI)	Two weeks	At each visit, disease severity will be assessed using the Eczema Area and Severity Index (EASI).

Trial Locations

Locations (1)

Department of Dermatology, Seoul National University Boramae Hospital; 🇰🇷 Seoul, Korea, Republic of